Copyright © Inderes 2011 - present. All rights reserved.
  • Senaste
  • Börs
    • Morning Review
    • Aktiejämförelse
    • Börskalender
    • Utdelningskalender
    • Aktieanalys
    • Artiklar
    • Insider Transactions
  • inderesTV
  • Portfölj
  • Forum
  • Premium
  • Femme
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • Om oss
    • Följda bolag
    • Teamet
Regulatoriskt pressmeddelande

LIFECARE ASA: Extraordinary General Meeting

Lifecare
Ladda ner börsmeddelandet

Lifecare ASA, a MedTech company developing next-generation continuous glucose monitoring (CGM) technology, will hold an Extraordinary General Meeting on 12 November 2025 at 16:00 (CET).

Reference is made to the contemplated partially underwritten rights issue announced by the Company on 22 October 2025, with gross proceeds of minimum NOK 80 million and up to NOK 100 million (the "Rights Issue"). 

In order to facilitate the subscription of shares and exercise of warrants in connection with the Rights Issue, the Board proposes that the General Meeting resolves to reduce the par value of the Company’s shares to NOK 0.10. 

The meeting will be conducted as a combined physical and digital meeting. Shareholders who wish to participate and vote at the Extraordinary General Meeting must be registered with a user profile in the meeting portal Orgbrain (www.orgbrain.no). Attendance will be possible either in person or digitally through Orgbrain. 

The notice with the complete agenda and supporting documents is available at https://lifecare.no/events/. 

About us
Lifecare ASA is a medical sensor company developing technology for sensing and monitoring of various body analytes. Lifecare's focus is to bring the next generation of Continuous Glucose Monitoring ("CGM") systems to market. Lifecare enables osmotic pressure as sensing principle. Lifecare's sensor technology is suitable for identifying and monitoring the occurrence of a wide range of analytes and molecules in the human body and in pets.

Contacts
For further information, please contact:

Joacim Holter, CEO, joacim.holter@lifecare.no, +47 40 05 90 40

Renete Kaarvik, CFO, renete.kaarvik@lifecare.no, +47 94 83 82 42

This information is subject to disclosure under the Norwegian Securities Trading Act, §5-12. The information was submitted for publication at 2025-10-22 14:00 CEST.

Attachments
LIFECARE ASA: Extraordinary General Meeting
Notice Of EGM 12 November 2025

Följ oss på våra kanaler i social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Ta kontakt
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • Om oss
  • Teamet
  • Jobba hos oss
  • Inderes som en investering
  • Tjänster för börsbolag
Vår plattform
  • FAQ
  • Servicevillkor
  • Integritetspolicy
  • Disclaimer
Inderes disclaimer gällande utförda aktieanalyser kan läsas här. För mer detaljerad information över de aktier som aktivt bevakas av Inderes, vänligen se respektive bolags bolagsspecifika sida på Inderes webbplats. © Inderes Oyj. Alla rättigheter förbehållna.